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and gene expressionNon-segmented negative-sense RNA viruses possess a unique mechanism for mRNA cap methylation. For
vesicular stomatitis virus, conserved region VI in the large (L) polymerase protein catalyzes both guanine-N-7
(G-N-7) and ribose 2'-O (2'-O) methyltransferases, and the twomethylases share a binding site for themethyl
donor S-adenosyl-l-methionine. Unlike conventional mRNA cap methylation, the 2'-O methylation of VSV
precedes subsequent G-N-7 methylation. In this study, we found that individual alanine substitutions in two
conserved aromatic residues (Y1650 and F1691) in region VI of L protein abolished both G-N-7 and 2'-O
methylation. However, replacement of one aromatic residue with another aromatic residue did not
signiﬁcantly affect themethyltransferase activities. Our studies provide genetic and biochemical evidence that
conserved aromatic residues in region VI of L protein essential for both G-N-7 and 2'-O methylations. In
combination with the structural prediction, our results suggest that these aromatic residues may participate
in RNA recognition.e and Technology, College of
ion of Environmental Health
rsity, 233 Parker Food Science
ax: +1 614 292 0218.
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Eukaryotic mRNAs possess at their 5′ terminus a 7mGpppN cap
structure that is essential for mRNA stability and efﬁcient translation
(Furuichi et al., 1977; Furuichi and Shatkin, 2000). Formation of the cap
structure usually requires four enzymatic reactions. First, an RNA
triphosphatase hydrolyses the 5' triphosphate end of the nascentmRNA
to yield a diphosphate (5' ppN). Second, the diphosphate RNA end is
cappedwithGMPbyanRNAguanylyltransferase via a covalent enzyme-
GMP intermediate to yield the GpppN cap structure. Third, the N-7
position of guanine cap is methylated by a guanine-N-7 (G-N-7) MTase
to yield 7mGpppN. Finally, for some eukaryotic mRNA, the cap structure
can be further methylated by a ribose-2′-O (2′-O) MTase to yield
7mGpppNm. The mRNA capping and methylation reactions are
conserved among all eukaryotes (Shuman and Schwer, 1995; Furuichi
and Shatkin, 2000; Shuman, 2001). In this conventional capmethylation
reaction, two methylase activities are carried out by separate enzymes,
each containing its own catalytic site and the binding site for themethyl
donor, S-adenosylmethionine (SAM).The non-segmented negative-sense (NNS) RNA viruses include a
wide range of signiﬁcant animal, human, and plant pathogens. The
NNS RNA viruses are classiﬁed into four families: the Rhabdoviridae, as
exempliﬁed by vesicular stomatitis virus (VSV) and rabies virus; the
Paramyxoviridae, as exempliﬁed by human respiratory syncytial virus
(RSV) and human parainﬂuenza virus type 3 (PIV3); the Filoviridae, as
exempliﬁed by Ebola and Marburg viruses; the Bornaviridae, as
exempliﬁed by Borna disease virus (BDV). With the exception of
Bornaviridae, NNS RNA viruses typically replicate in the cytoplasm.
These viruses share a common strategy for gene expression and
replication (Rose and Whitt, 2001; Whelan et al., 2004). For many
years, VSV has been used as a model to study the replication and gene
expression of NNS RNA viruses. The viral genomic RNA is tightly
encapsidated by the nucleocapsid (N) protein, forming the N-RNA
complex that serves as a functional template for replication and
transcription, which carried out by RNA-dependent RNA polymerase
(RdRP). The viral RdRp is comprised of the catalytic subunit large (L)
polymerase protein and the accessory phosphoprotein (P) (Emerson
and Wagner, 1972; Emerson and Yu, 1975). During transcription, the
RdRp complex transcribes the viral genome into ﬁve mRNAs in a
sequential and gradient manner, such that 3′ proximal genes are
transcribed more abundantly than 3′ distal genes (Abraham and
Banerjee, 1976; Ball and White, 1976; Villarreal et al., 1976). These
mRNAs are capped and methylated at the 5′ end and polyadenylated
at the 3′ end (Iverson and Rose, 1981). During replication, it yields
242 X. Zhang et al. / Virology 408 (2010) 241–252full-length antigenomic RNA, which in turn results in the synthesis of
genomic RNA. How polymerase complex controls these two distinct
RNA synthesis is still poorly understood.
The VSV L protein is a 241-kDa multifunctional protein. Structure
has not been determined for any of portion of L protein within NNS
RNA viruses. In addition to the polymerase function, the L protein
possesses all the enzymatic activities for mRNA processing such as
capping, methylation and polyadenylation (Abraham et al., 1975;
Moyer, 1981; Hercyk et al., 1988; Poch et al., 1990; Li et al., 2005,
2006, 2008, 2009; Galloway and Wertz, 2008; Ogino et al., 2010). In
recent years, many breakthroughs have been made in VSV mRNA
processing. These discoveries were facilitated by the ability of puriﬁed
VSV to synthesize RNA in vitro (Baltimore et al., 1970) and the ability
of highly puriﬁed L protein to modify short virus-speciﬁc mRNA in
vitro (Ogino and Banerjee, 2007; Li et al., 2008; Rahmeh et al., 2009).
Recent studies revealed that the mechanism of mRNA cap formation
in VSV is distinct from that of all other known capping reactions.
Speciﬁcally, capping of VSV mRNA is achieved by a novel polyribo-
nucelotidyltransferase (PRNTase) which transfers a monophosphate
RNA onto a GDP acceptor through a covalent L-RNA intermediate
(Ogino and Banerjee, 2007; Li et al., 2008; Ogino et al., 2010).
However, all other known capping reactions are catalyzed by a RNA
guanylyltransferase, which transfers GMP derived from GTP onto a
diphosphate acceptor RNA (Furuichi and Shatkin, 2000). Previously,
we demonstrated that a newmotif, GxxT[n]HR, in conserved region V
(CRV) of the L protein is essential for PRNTase activity (Li et al., 2008).
Mutation to this motif resulted in the synthesis of short abortive
transcripts that lack a cap structure (Li et al., 2008). A biochemical
study showed that it is the H residue in GxxT[n]HR motif involved in
the formation of the covalent L-RNA intermediate (Ogino et al., 2010).
In addition, it was shown that mRNA capping reaction of Chandipura
virus, another member within the family Rhabdoviridae, utilizes the
same mechanism (Ogino and Banerjee, 2010). Whether this uncon-Fig. 1. Structure-based amino acid sequence alignments of conserved domain VI of represent
vaccinia virus VP39. The conserved motifs (X and I to VIII) correspond to the SAM-dependen
are shaded. MTase catalytic and SAM binding are shown by boxes. Predicted alpha-helical reg
RrmJ and predicted structure for the NNS RNA viruses; EBOM, Ebola virus; VSIV, VSV Indian
VP39, vaccinia virus 2'-O MTase VP39.ventional mechanism is conserved in other families of NNS RNA
viruses is not known.
Like the unconventional capping mechanism, methylation of the
VSV mRNA cap structure is also unique. Speciﬁcally, the G-N-7 and
2'-O methylations of VSV mRNA are accomplished by a single protein:
the conserved domain VI of the L protein (Grdzelishvili et al., 2005; Li
et al., 2005, 2006, 2007, 2008; Galloway and Wertz, 2008; Galloway
et al., 2008; Rahmeh et al., 2009). Sequence alignment and structure
prediction identiﬁed a putative 2'-O MTase in conserved region VI of
the L protein (Bujnicki and Rychlewski, 2002; Ferron et al., 2002).
Alterations to the MTase catalytic motif (K-D-K-E) in conserved
domain VI of VSV L protein abolished both G-N-7 and 2'-O
methylations, suggesting that a single active site is essential for both
methylase activities (Li et al., 2005). This is in contrast to all other
known MTases, in which the two activities are catalyzed by either
separate proteins (Shuman and Schwer, 1995; Furuichi and Shatkin,
2000) or two different regions in one protein (Reinisch et al., 2000).
Interestingly, substitutions to the SAM binding site of VSV MTase
disrupted methylation at the guanine-N-7 (G-N-7) position or at both
the G-N-7 and ribose-2'-O (2'-O) positions of the mRNA cap,
suggesting that the two methylase activities share one SAM binding
site, and methylation of the G-N-7 position is not required for 2'-O
methylation (Li et al., 2006). Using puriﬁed recombinant L protein and
in vitro-synthesized short RNA, it was demonstrated that 2'-O
methylation of VSV precedes and facilitates subsequent G-N-7
methylation, and two methylase activities require different RNA
sequence and length in methylation (Rahmeh et al., 2009). Therefore,
VSV capmethylation is mechanistically different from all other known
mRNA cap methylation reactions.
Although VSV mRNA MTase has been genetically and biochemi-
cally characterized, the mechanism by which a single region VI of L
protein catalyzes twomethylations is not fully understood. To acquire
methylation, the MTase usually directly or indirectly contacts RNAative NNS RNA virus L proteins with known 2'-O methyltransferase, the E. coli RrmJ and
t MTase superfamily (Schluckebier et al., 1995). Residues modiﬁed in the present study
ions are shown by the cylinders and the ß-sheet regions by the arrows. STR, structure of
a type; HRSV, human respiratory syncytial virus; RRMJ, E. coli heat shock 2'-O MTase;
Fig. 2. Recovery of recombinant VSV with mutations in the L gene. (A) The plaque morphology of each of the recombinant viruses is shown compared to rVSV. Plaques were
developed after 24 h of incubation. Recombinants Y1650A and F1691A did not form plaques. (B) Viral titer of recombinant VSV in BSRT7 cells. BSRT7 cells were inoculated with each
of the indicated viruses at an MOI of 3, and the viral yield was determined at 24 hpi by plaque assay. (C) Single-step growth curve of recombinant VSV in BHK-21 cells. Conﬂuent
BSRT7 cells were infected with individual viruses at a TCID50 of 20. After 1-h incubation, the inoculum was removed, the cells were washed with DMEM, and fresh medium
(containing 2% fetal bovine serum) was added, followed by incubation at 37 °C. Samples of supernatant were harvested at the indicated intervals over a 48-h time period, and the
virus titer was determined by TCID50. Titers are expressed as the mean ± the standard deviation of three independent single-step growth experiments.
243X. Zhang et al. / Virology 408 (2010) 241–252substrate (Lockless et al., 1998; Hu et al., 1999; Quiocho et al., 2000;
Shuman, 2001; Li et al., 2004; Cowling, 2010). However, this putative
substrate binding site has not been suggested for any of the NNS RNA
viruses. In this study, we performed further sequence alignment and
structure prediction of VSV MTase that suggested several aromatic
residues in region VI of VSV L protein as the putative RNA binding site.
Subsequently, we performed a systematic mutagenesis analysis of this
putative substrate binding site and determined its role in mRNA cap
methylation. We demonstrated that the mutation to the aromatic
residue abolished both G-N-7 and 2'-O methylations. Although RNA
binding has not been directly measured in this study, combined with
the structural prediction, our results suggest that these aromatic
residues may participate in RNA recognition.
Results
Prediction of putative substrate binding site in VSV MTases and
mutagenesis strategy
Based on sequence alignment and structure modeling, domain VI
of the L protein in NNS RNA viruses shares homology with known
2'-O-MTases such as vaccinia virus VP39 and Escherichia coli. RRMJ
(Bujnicki and Rychlewski, 2002; Ferron et al., 2002). To acquire
methylation, the RNA substrate must come in contact with the MTase.
RNA cap recognition often requires stacking between the base of the
cap and aromatic rings from a protein (Lockless et al., 1998; Hu et al.,
1999; Quiocho et al., 2000; Egloff et al., 2002; Decroly et al., 2008). The
crystal structure of a complex comprising vaccinia VP39, the
methylation inhibitor SAH, and an mRNA analog 5' 7mGppp-capped
single-stranded RNA hexamer has been solved (Hodel et al., 1996;
Hodel et al., 1998; Hu et al., 1999). It was found that the recognition of
a methylated base is achieved by stacking between two aromatic
residues (Y22 and F180), and the methyl group is in contact with
residue Y204. In addition, the carboxyl groups of residues D182 and
E233 form hydrogen bonds to the NH and NH2 of the guanosine in
VP39.
In an attempt to identify the putative cap recognition site in VSV
MTases, our strategy was to select conserved residues in region VI of L
proteins of NNS RNA viruses that are physicochemically similar tothose involved in substrate recognition in VP39. Sequence alignment
showed that there are a number of aromatic residues that are highly
conserved in the MTase domain of L proteins (Fig. 1). Aromatic
residues at positions 1650 (Y), 1691(F or Y), and 1835 (Y) are highly
conserved in L proteins of NNS RNA viruses although there are some
exceptions. For example, these aromatic residues are not conserved in
nuclear BDV; 1691(F or Y), and 1835 (Y) are absent in plant
rhabdovirus; and 1650 (Y) is not conserved in HRSV (Fig. 1). Aromatic
residues at positions 1742 (W), 1744 (Y), 1745 (F) and 1816 (F) are
conserved in the L proteins of Rhabdoviridae and some Paramyxovir-
idae and Filoviridae. Therefore, these aromatic residues were selected
as putative equivalents of Y22, F180, and Y204 in VP39. Unfortunately,
there is no amino acid precisely aligned with D182 and E233 in VP39.
With the exception of two acidic amino acids in the catalytic site
(K1651-D1762-K1795-E1833), position E1764 is also conserved in all
L proteins. In addition, D1735 is highly conserved although it is W in L
protein of some viruses, such as measles virus (Fig. 1). Actually,
residue D1735 is a part of the SAM binding motif (GxGxG……D).
Previously, we have shown that an alanine substitution for D1735
diminished both G-N-7 and 2'-O methylations to 35% of the level of
rVSV (Li et al., 2006). Thus, we targeted E1764 as a candidate for the
role of VP39 residues D182 and E233. Finally, other highly conserved
amino acid residues (N1692, S1693, P1709, L1757 and S1827) within
domain VI of L proteins were also selected for mutagenesis.
Previously, a serine residue has been shown to be involved in RNA-
protein interaction of E. coli. 2'-O MTase, RRMJ (Hager et al., 2004).
Therefore, we selected themost conserved serine residues (S1693 and
S1827) for mutagenesis.
Recovery of recombinant viruses with L gene mutations
To test our prediction, we ﬁrst performed alanine scanning
mutagenesis in the putative RNA substrate binding site. All of the
above amino acid residues were mutated into alanine individually in
the L gene of an infectious clone of VSV. Recombinant VSV carrying
these mutations were recovered from cDNA clone as described in
Materials and methods. As shown in Fig. 2A, each of the L gene
mutations yielded viable recombinant virus. However, most viruses
showed defects in viral growth as judged by their plaquemorphology.
Fig. 3. Effect of L gene mutations onmRNA G-N-7methylation in vitro. (A) Synthesis of viral mRNA in vitro. Transcription reactions were performed in vitro in the presence of [α-32P]
GTP, the RNAwas puriﬁed and analyzed by electrophoresis on acid-agarose gels. The products were detected by phosphorimager. The identity of VSVmRNA (G, N, and P/M) is shown
on the right. (B) Quantitative analysis of synthesized mRNA for each recombinant virus. Three independent experiments were shown. For each mRNA the mean ± the standard
deviation was expressed as a percentage of that observed for rVSV. (C) Analysis of G-N-7 methylation by TLC. Viral mRNA was synthesized in vitro in the presence of 15 μCi [α32P]
GTP. The RNA was puriﬁed, digested with 2 units of TAP, and subjected to TLC on PEI-F cellulose sheets in 1.2 M LiCl2 solution. The plates were dried, and the spots were visualized
using a phosphorimager. The migration of the markers 7mGp and Gp is indicated. (D) Quantitative analysis of G-N-7 methylation from three independent experiments. For each
virus, the released 7mGp was expressed as a percentage of the total released cap structure (7mGp and Gp). Data are shown as the mean ± the standard deviation.
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in diameter. However, alterations to amino acid residues S1693,
W1742, F1745, E1764, S1827, and Y1835 resulted in formation of
signiﬁcantly smaller plaques. After 48 h of incubation, the average
plaque diameter was 0.6±0.2 mm for S1693A, 2.3±0.4 mm for
W1742A, 1.9±0.4 mm for F1745A, 1.3±0.4 mm for E1764A, and
0.9±0.2 mm for S1827A, 2.8±0.4 mm for Y1835A (Fig. 2A). Most
interestingly, two recombinant viruses F1691A and Y1650A did not
form plaques in either Vero or BSRT7 cells, although they were able to
produce signiﬁcant cytopathogenic effect (CPE) in both cell lines. This
suggests that these two recombinants had a defect in cell-to-cell
spread. Therefore, the viral titer for these two viruses was determined
by TCID50 method in BSRT7 cells. The entire L gene of each virus was
ampliﬁed by RT-PCR, sequenced, and the presence of the desired
mutationwas conﬁrmed in all of the viruses.With the exception of the
F1816A-mutated virus, no additional mutations were identiﬁed. Virus
F1816A contained one additional nucleotide change G10177T which
resulted in coding change M1815I. Thus, this virus was named
F1816AD. Subsequently, we isolated a fresh F1816A from an
independent transfection, and sequence conﬁrmed that no additional
changes were present within the L gene.
To examine the effect of these mutations on viral growth, we
determined the virus yield in infected cells. Brieﬂy, BSRT7 cells were
infected with each virus at a MOI of 3 and the viral titer was
determined at 24 h after inoculation. Recombinants E1764A, N1692A,
S1693A and S1827A had a 3 logarithmic growth defect compared
with rVSV (Fig. 2B). Recombinants W1744A and F1745A had a 2logarithmic growth defect (Fig. 2B). Since recombinant F1691A and
Y1650A were not able to form plaques, we monitored the kinetics of
release of infectious virus by single-step growth assay in BSRT7 cells
using TCID50 assay by Reed–Muench method (Reed and Muench,
1938). Brieﬂy, BSRT7 cells were infected with 20 TCID50 of each of the
indicated recombinants and viral replication was determined at time
points from 0 to 48 h postinfection. As shown in Fig. 2C, both F1691A
and Y1650A had signiﬁcant defects in viral replication as compared to
that of rVSV. Wild type rVSV reached peak titer (109.8 TCID50/ml) at
12 h post-infection. However, both Y1650A and F1691A reached peak
titer (106.4 TCID50/ml) at 30 h post-infection. Taken together, these
results demonstrate that amino acid substitutions in the putative RNA
binding site signiﬁcantly diminished viral replication.
Identiﬁcation of amino acids in the putative RNA substrate binding site
that are essential for G-N-7 methylation
To examine the effect of amino acid substitutions in the putative
RNA binding site on mRNA cap methylation, in vitro transcription
reactions were performed as described previously (Li et al., 2005).
Brieﬂy, 20 μg of virus was activated with detergent and incubated
with nucleoside triphosphates supplemented with [α-32P]GTP as
described in Materials and methods. Total RNA was extracted,
puriﬁed, and analyzed by acid-agarose gel electrophoresis as
described previously (Li et al., 2005). All of the recombinant viruses
were able to synthesize similar amounts of mRNA except for F1691A
and Y1650A. These two recombinants synthesized approximately 50%
Fig. 4. Effect of L gene mutations on mRNA G-N-7 and 2'-O methylation in vitro. (A) Analysis of mRNA cap methylation by nuclease P1 digestion. Viral mRNA was synthesized in the
presence of [3H]SAM, the RNAwere puriﬁed and digested with 5 unit of nuclease P1, and the products were developed on PEI-F cellulose sheets. The plates were dried, and the spots
were visualized by phosphorimage analysis. (B) Primer extension of viral mRNA. RNA from panel A was examined by primer extension using a primer designed to anneal to the N
mRNA. Products were developed by electrophoresis on denaturing 6% polyacrylamide gels. (C) Quantitative analysis of G-N-7 and 2'-O methylation from three independent
experiments. For each virus, methylation was expressed as a percentage of the released 7mGpppAm compared to that of rVSV. Data were shown as the mean ± the standard
deviation. (D) Analysis of mRNA capmethylation by RNase T2 and TAP. Puriﬁed RNAswere digested with TAP and RNase T2 prior to TLC analysis. Themigration of the 7mGpmarker is
shown, and the presumed pAmpAp spot is identiﬁed. (E) Measurement of mRNA cap methylation by [3H]SAM incorporation using scintillation counting. Data were calculated from
three independent experiments.
245X. Zhang et al. / Virology 408 (2010) 241–252of the level of the rVSVmRNA (Fig. 3A and B). To compensate for these
defects in mRNA synthesis, the amount of these viruses used in the in
vitro transcription reactions was increased to 40 μg.
To analyze the G-N-7 methylation, 8.8 μl of each in vitro-
synthesized mRNA was treated by TAP. TAP speciﬁcally cleaves the
pyrophosphate bond of the GpppN cap to yield Gp or, if the cap
structure is methylated, 7mGp. These products are resolved by TLC on
polyethyleneimine (PEI) cellulose F sheets. For rVSV, when tran-
scription reactions were performed in the presence of 1 mM SAM, a
fully G-N-7 methylated cap (7mGp) was detected after TAP digestion
(Fig. 3C, lane 1). This radioactive spot co-migrated with the marker
7mGp as visualized by UV shadowing. However, an unmethylated cap
(Gp)was detectedwhen the transcription reaction was performed in
the presence of 100 μM SAH (Fig. 3C, lane 2). Quantitative analysis of
three independent experiments showed that the total of 14 mutants
can be classiﬁed into three different groups (Fig. 3C and D). Viruses in
the ﬁrst group abolished G-N-7 methylation. These viruses included
Y1650A, F1691A, and E1764A, which yielded 6.5%, 5.5%, and 8.8% of
G-N-7 methylated cap, respectively. Viruses that had a moderate
defect in G-N-7 methylation were classiﬁed into group 2. These
viruses included N1692A, S1693A, F1745A, and S1827A, which
yielded 30-60% of G-N-7 methylated cap. Viruses that did not have
a signiﬁcant defect in G-N-7methylationwere classiﬁed into group 3.
This group includes P1709A, W1744A, L1757A, F1816A, F1816AD,
and Y1835A. These data clearly demonstrate that alterations to two
aromatic amino acid residues (Y1650A and F1691A) and one acidic
residue (E1764A) abolish G-N-7 methylation.Identiﬁcation of amino acids in the putative RNA substrate binding site
that are essential for both G-N-7 and 2'-O methylation
To examine the effect of these mutations on both G-N-7 and 2'-O
methylations, in vitro transcription reactions were performed in the
presence of [3H]SAM. Total RNAs were extracted, puriﬁed, and
subjected to nuclease P1 digestion followed by TLC on PEI cellulose
F sheets. Nuclease P1 cleaves the bond between the 3′-hydroxyl and
5′-phosphoryl group of adjacent nucleosides. Theoretically, digestion
of VSV mRNAs by P1 should yield 7mGpppAm (double methylated),
GpppAm (only 2'-O methylated), 7mGpppA (only G-N-7 methylated),
or GpppA (unmethylated), depending on the extent of cap methyl-
ation. The standard markers for these products were visualized by UV
shadowing. For rVSV, when transcription reactions were performed in
the presence of 50 μM of [3H]-SAM, a doubly methylated cap
(7mGpppAm) was detected after P1 digestion (Fig. 4A, lane 1).
However, no detectable products were observed when 1 mM of SAH
was included in the reaction, conﬁrming that both G-N-7 and 2'-O
methylations were completely inhibited (Fig. 4A, lane 2). Phenotypes
of a total of 14 mutants are shown in Fig. 4A.
Quantitative analysis of three independent experiments showed
that these mutants fall into three categories (Fig. 4C). Recombinants
Y1650A, F1691A, and E1764A reduced both G-N-7 and 2'-O methyla-
tions to an undetectable level (Fig. 4A and C). Recombinants N1692A,
S1693A, F1745A, and S1827A were able to synthesize doubly
methylated cap. However, the abundance of a fully methylated cap
was diminished 30-60%. Viral mutants defective in G-N-7methylation
Fig. 5. The role of Y1650 and F1691 in mRNA cap methylation. (A) The plaque morphology of each of the recombinant viruses carrying mutation in Y1650 and F1691. Plaques were
developed after 24 h of incubation. (B) Viral titer of recombinant VSV in BSRT7 cells. BSRT7 cells were infected by indicated viruses at anMOI of 3, and the viral yield was determined
at 24 hpi. (C) Analysis of G-N-7methylation by TAP digestion. Puriﬁed RNAswere digested by TAP, and the products were developed on PEI-F cellulose sheets. Themarkers 7mGp and
Gp were shown. (D) Quantitative analysis of G-N-7 methylation from three independent experiments. (E) Analysis of G-N-7 and 2'-O methylation by nuclease P1 digestion. Viral
mRNA was synthesized in the presence of [3H]SAM, puriﬁed RNA were digested with 5 unit of nuclease P1, and the products were developed on PEI-F cellulose sheets. (F) RNA from
panel E was examined by primer extension using a primer designed to anneal to the N mRNA. (G) Quantitative analysis of G-N-7 and 2'-O methylations from three independent
experiments.
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P1709A, W1744A, L1757A, F1816A, and F1816AD, and Y1835A
yielded similar amounts of doubly methylated cap compared to that
of rVSV, conﬁrming that they did not affect either G-N-7 or 2'-O
methylation (Fig. 4A and C). Interestingly, none of the viral mutants
was defective only either in G-N-7 or 2'-O methylation. To further
conﬁrm these results, we performed additional cap hydrolysis. The
RNA samples from rVSV, Y1650A, F1691A and E1764A were digested
by RNase T2 and TAP. RNase T2 is an endoribonuclease that cleaves
the phosphodiester bonds on the 3' side of A residues. Digestion of the
VSV mRNA cap structure with RNase T2 should yield 7mGpppAmA if
the cap structure was doubly methylated. Further digestion of this
product by TAPwould yield 7mG and AmA. As shown in Fig. 4D, double
digestion of RNA synthesized from rVSV yielded two radioactive spots.
The ﬁrst spot comigrated with the 7mGp marker, representing G-N-7
methylation. Presumably, the second spot was AmA, representing 2'-O
methylation. The identity of these spots was also consistent with our
previous publications (Li et al., 2005, 2006). However, these two spots
were undetectable in RNA synthesized from rVSV in the presence of
SAH, Y1650A, F1691A, and E1764A (Fig. 4D, lanes 2–5), conﬁrming
that both G-N-7 and 2'-O methylations were abolished. To ensure
there is an equivalent amount of RNA synthesized from eachmutant, a
primer extension assay was performed to detect the ﬁrst 130 nt of N
mRNA. As shown in Fig. 4B, the amount of RNA used for cap hydrolysis
is indistinguishable for each mutant. Therefore, these results further
conﬁrmed that Y1650A, F1691A, and E1764A lack both G-N-7 and
2'-O methylations.
To further conﬁrm the extent of cap methylation, the amount of
[3H]-SAM incorporated into the viral mRNA was measured byscintillation counting and the dpm normalized to the amount of
RNA synthesized. As shown in Fig. 4E, the amount of [3H] for
recombinants Y1650A, F1691A and E1764A was about 5-10% that of
rVSV. The amount of [3H]-SAM incorporation for recombinants
N1692A, S1693A, F1745A, and S1827A was about 30–50% of that of
rVSV. Recombinant P1709A, W1744A, L1757A, F1816A, and F1816AD,
and Y1835A viruses showed comparable levels of [3H]-SAM incorpo-
ration to that of rVSV. Again, these results are consistent with cap
hydrolysis by nuclease P1 digestion. Taken together, these experi-
ments demonstrate that alanine substitutions for two aromatic
residues (Y1650A and F1691A) and an acidic residue (E1764A) in
VSV MTase abolish both G-N-7 and 2'-O methylation.
Cap methylation requires maintenance of two aromatic residues
It has been demonstrated that RNA cap recognition typically
requires stacking between the base of the cap and aromatic rings from
a protein (Lockless et al., 1998; Hodel et al., 1998; Hu et al., 1999;
Quiocho et al., 2000; Egloff et al., 2002; Decroly et al., 2008). If
aromatic residues are, indeed, involved in RNA cap recognition,
maintenance of the aromatic ring may be essential for mRNA cap
methylation. To further demonstrate the role of aromatic residues
F1691 and Y1650 in VSV mRNA cap methylation, each of these two
aromatic residues were changed to two other possible aromatic
residues (Y,W or F) in the VSV infectious clone. A total of four possible
mutants (F1691Y, F1691W, Y1650F, and Y1650W)were generated. As
shown in Fig. 5A, each of these mutations yielded viable recombinant
virus. Interestingly, changing from one aromatic residue to another
aromatic residue did not signiﬁcantly affect the size of viral plaques.
Fig. 6. The role of E1764 in mRNA cap methylation. (A) The plaque morphology of each of the recombinant viruses carrying a mutation for E1764. Plaques were developed after 24 h
of incubation. (B) Viral titer of recombinant VSV in BSRT7 cells. BSRT7 cells were infected by indicated viruses at anMOI of 3, and the viral yield was determined at 24 hpi. (C) Analysis
of G-N-7 methylation by TAP digestion. Puriﬁed RNAs were digested by TAP, and the products were developed on PEI-F cellulose sheets. (D) Quantitative analysis of G-N-7
methylation from three independent experiments. (E) Analysis of G-N-7 and 2'-O methylation by nuclease P1 digestion. (F) RNA from panel E was examined by primer extension
using a primer designed to anneal to the N mRNA. (G) Quantitative analysis of G-N-7 and 2'-O methylations from three independent experiments.
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able from that of rVSV (Fig. 5B). In sharp contrast, alanine
substitutions for these aromatic residues resulted in recombinant
viruses that did not form plaques (Fig. 2A) and signiﬁcantly
diminished viral replication (Fig. 2C). These data suggest that
maintenance of an aromatic residue at positions 1691 and 1650 is
essential for viral replication.
To examine G-N-7 methylation, in vitro transcription reactions
were performed in the presence of [α-32P]GTP. The RNA was puriﬁed
as described, the cap structure was hydrolyzed with TAP, and the
products were analyzed by TLC on PEI-F cellulose sheets. TAP
digestion demonstrated that F1691Y and F1691W mutants exhibited
85% and 82% of the rVSV G-N-7 methylation, respectively (Fig. 5C).
Y1650F and Y1650Wmutants showed 88% and 90% of the rVSV G-N-7
methylation, respectively (Fig. 5C and D). Thus, changing from one
aromatic residue to another aromatic residue does not signiﬁcantly
affect G-N-7 methylation.
To examine 2'-O methylation, the in vitro transcription reaction
was performed in the presence of [3H]-SAM. The RNAs were puriﬁed
and subjected to nuclease P1 digestion. P1 digestion showed that all of
these mutants were able to synthesize doubly methylated caps
(Fig. 5E). Quantitative analysis showed that Y1650F, Y1650W, F1691Y,
and F1691W yielded 90%±2%, 90%±3%, 88%±4%, and 80%±5% of
7mGpppAm, respectively (Fig. 5G). Primer extension showed that
there were equivalent amounts RNA synthesized from each mutant
(Fig. 5F). Thus, these data demonstrate that other aromatic residues
can substitute for Y1650 and F1691 in the VSV MTase. These resultssuggest that VSV mRNA cap methylation may require the stacking
interaction between the base of the cap and an aromatic residue at
position 1650 and 1691.The role of E1764 in VSV mRNA cap methylation
To further characterize the role of E1764 in VSV mRNA cap
methylation, wemutated this residue to D (maintenance of charge), Q
(maintenance of size) or K (changing charge). Using reverse genetics,
recombinant viruses carrying these mutations were successfully
recovered. As shown in Fig. 6A, the plaque sizes of E1764D, E1764Q
and E1764K-mutated viruses were signiﬁcantly diminished as
compared to that of rVSV. These recombinants have a moderate
defect (2-3 log viral yields) in replication in BSRT7 cells (Fig. 6B).
The in vitro transcription reaction was performed using puriﬁed
viruses and mRNA cap methylation was analyzed as described above.
As shown in Fig. 6C, these recombinant viruses are defective in G-N-7
methylation compared to rVSV. Quantitative analysis showed that
E1764D, E1764Q and E1764K yielded 22%±5%, 17%±8%, and 15%±
6% of 7mGp, respectively (Fig. 6D). Nuclease P1 digestion showed that
E1764D, E1764Q and E1764K had a signiﬁcant reduction in both G-N-
7 and 2'-O methylation (Fig. 6E), yielding 19% ± 6%, 15%±9%, and
16%±8% of 7mGpppAm, respectively (Fig. 6G). Equivalent amounts of
RNA were synthesized from each mutant as conﬁrmed by primer
extension (Fig. 6F). Therefore, changing of residue E at position 1764
to any other amino acids, even the very conservative change to D,
Fig. 7. Effect of SAM and SAH concentration on G-N-7 methylation of rVSV and Y1835A. (A) Viral mRNA was synthesized in vitro in the presence of different concentration of SAM
and 15 mCi of [α-32P]GTP without a cell lysate. Puriﬁed RNA was digested with 2 units of TAP, and the products were analyzed by TLC on PEI F cellulose sheets. The migration of the
markers 7mGp and Gp is indicated. (B) Recombinant Y1835A requires a higher concentration of SAM for G-N-7 methylation. Quantitative analysis was performed on three
independent experiments. For each virus, the released 7mGp (mean ± standard the standard deviation) was expressed as a percentage of the total released cap structure. (C) G-N-7
methylation of Y1835A is more sensitive to SAH inhibition. Viral mRNA was synthesized in vitro in the presence of 200 μM of SAM without a cell lysate, 15 mCi of [α-32P]GTP, and
different concentrations of SAH. Quantitative analysis was performed on three independent experiments.
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suggest that E1764 is critical for both G-N-7 and 2'-O methylation.
Y1835A requires a higher SAM concentration and it is more sensitive to
MTase inhibitor
There are a total of 7 aromatic residues that were selected for
mutagenesis. Mutants Y1650A and F1691A abolished G-N-7 and 2'-O
methylation. F1745A had a moderate reduction in methylation. Other
aromatic residues (W1742, Y1744, F1816 and Y1835) did not have a
signiﬁcant impact on mRNA cap methylation. To further characterize
the role of these amino acids, wemonitored the effect of SAM and SAH
concentration on mRNA cap methylation of these mutants. Brieﬂy, an
increasing amount of either SAM or SAH was added to the in vitro
transcription reaction in the presence of [α-32P]GTP, RNAs were
puriﬁed and treated with TAP. For rVSV, a full G-N-7 methylation was
achieved when the reaction was performed in the presence of 100 μM
of SAM (Fig. 7A and B). In contrast, Y1835A requires a much higher
SAM concentration (1 mM) to achieve full G-N-7 methylation (Fig. 7A
and B). For rVSV, G-N-7 methylation was completely inhibited when
200 μM of SAH was added to the reaction (Fig. 7C). However, Y1835A
was much more sensitive to SAH inhibition and G-N-7 methylation
was almost completely inhibited by the addition of 20 μM of SAH
(Fig. 7C). Thus, these experiments show that Y1835A requires higher
SAM concentration for methylation and it is more sensitive to an
MTase inhibitor. In contrast, alterations to other three aromatic
residues (W1742, Y1744 and F1816) resulted in viruses with
properties similar to rVSV (data not shown). These results suggest
that an alanine substitution for Y1835 alters the afﬁnity of SAM and
SAH in mRNA cap methylation.
Discussion
Prior to this study, the putative RNA substrate recognition site had
not been suggested for anyMTase in the L protein of NNS RNA viruses.
Using the prototype rhabdovirus VSV as a model, we performed a
systematic mutagenesis analysis of a putative substrate binding site in
the MTase region of L polymerase and determined the effect of these
changes on VSV mRNA cap methylation. We found that individual
amino acid substitutions to two aromatic residues (Y1650 and F1691)
and one acidic amino acid residue (E1764) abolished both G-N-7 and
2'-O MTases. Substitution for F1745 resulted in a moderate defect in
both methylations. Mutation of Y1835 resulted in recombinant virus
that was more sensitive to SAM and SAH concentration. We further
demonstrated that MTase-defective viruses also signiﬁcantly dimin-
ished replication in cell culture. These ﬁndings suggest that aminoacid residues in VSV methylase are essential for both G-N-7 and 2'-O
MTases and may function as a putative RNA recognition site.
Identiﬁcation of amino acids residues essential for mRNA cap recognition
The structure of several cellular and viral mRNA 2'-O MTases has
been determined (Hodel et al., 1996; Hager et al., 2002; Egloff et al.,
2002; Zhou et al., 2007). To achieve 2'-O methylation, RNA substrate
contacts with the cap recognition site requires stacking between the
base of the cap and aromatic rings from a MTase (Bugl et al., 2000;
Lockless et al., 1998; Hu et al., 1999; Quiocho et al., 2000; Egloff et al.,
2002; Decroly et al., 2008). Vaccinia VP39 is one of the best
characterized 2'-O MTases. In VP39, it was found that the recognition
of a methylated base is achieved by stacking between two aromatic
residues (Y22 and F180) (Hodel et al., 1996; Hu et al., 1999). Based on
structure modeling and mutagenesis analysis, it was shown that
residue F24 in West Nile virus (WNV) methylase (NS5) (Dong et al.,
2007) and Y29 and F173 in feline coronavirus 2'-O MTase (nsp16)
(Decroly et al., 2008) may play an equivalent role to residue Y22 in
VP39. The cellular cap binding protein eIF4E recognizes the cap by
stacking between W56 and W102 (Marcotrigiano et al., 1997). In all
known cases, aromatic residues are involved in cap binding and
substrate recognition.
Sequence alignment and structure prediction suggest that domain
VI of VSV L protein shares homology with known 2'-OMTases. We are
particularly interested in the highly conserved aromatic amino acids
since they may be involved in cap recognition. Among 7 aromatic
residues we selected, Y1650 and F1691 were the most critical amino
acids essential for mRNA cap methylation. Speciﬁcally, alanine
substitutions for Y1650 and F1691 abolished both G-N-7 and 2'-O
methylation (Fig. 3C and D). However, replacement of one aromatic
residue with another aromatic residue (Y1650F, Y1650W, F1691Y,
and F1691W) did not signiﬁcantly affect the methyltransferase
activities (Fig. 5C and E), suggesting that maintenance of the aromatic
residue is required for RNA substrate recognition and methylation.
Similar to other known 2'-O MTases, these two residues may have a
stacking interaction with the mRNA cap that lead to correct
positioning of capped RNA into the catalytic site. Based on the
predicted structural model for the VSV MTase (amino acid residues
from 1644 to 1842 in the L protein) (Galloway et al., 2008), the
residues Y1650 and F1691 are located far from each other with a
distance of 17.3 Å between their alpha carbon atoms. Y1650 is located
in the middle of the ﬁrst helix, and the F1691 is at the very C-terminal
of the second helix (Fig. 8A). Perhaps, a stacking interaction with one
aromatic residue causes a conformational and structural change in the
VSVmethylase, which results in the interactionwith another aromatic
Fig. 8. Critical amino acids in the predicted structure of VSV MTase. (A) The model was generated based on the previous predicted structure of VSV MTase (amino acid residue from
1644 to 1842 in L protein) (Galloway et al., 2008) using PyMOL software. Alpha helices are shown in blue and beta strands are shown in pink. SAM and the side chains of critical
residues are shown in sticks, and the oxygen atoms and nitrogen atoms are shown in red and blue, respectively. For SAM molecule, the carbon atoms are green. For the three
important amino acids (Y1650, F1691 and E1764) identiﬁed in this study, their side-chain carbon atoms are highlighted in orange. For the predicted catalytic residues (K1651,
D1762, K1795 and E1833), the carbon atoms are shown in purple. (B) Cap binding site of vaccinia virus 2'-OMTase, VP39. Themodel was generated from the crystal structure of VP39
(PDB code: 1AV6) using PyMOL. The side chains of amino acid residues (Y22, F180, E233 and D182) involved in binding of 7mGp cap are shown as sticks.
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prevent these stacking interactions, which, in turn, affects mRNA
methylation. Interestingly, recombinants Y1650A and F1691A were
not able to form plaques in either BSRT7 or Vero cells. During the
plaque assay, we found that cells in six-well plates were either
completely killed or intact without generating regions of cell
destruction. However, they were still able to cause cell lysis and
produce CPE in both BSRT7 and Vero cells. It is likely that these viruses
were replication competent, but had a defect in cell-to-cell spread. In
addition, recombinant Y1650A and F1691A synthesized only 50% of
viral mRNAs in vitro compared to rVSV (Fig. 3A and B). Perhaps,
alanine substitution to Y1650 and F1691 may have an effect on the
overall folding and/or stability of L protein.
We also found that F1745 and Y1835 play a role in mRNA cap
methylation. Recombinant F1745A exhibited a signiﬁcant defect in
both G-N-7 and 2'-Omethylation (Fig. 3C). Interestingly, recombinant
Y1835 requires a higher SAM concentration for methylation and it is
more sensitive to SAH inhibition (Fig. 7). This is similar to the
phenotype we observed in one of the mutants (G1674A) in the
putative SAM binding site (Li et al., 2006). Y1835 is conserved in the L
proteins of almost all NNS RNA viruses and is adjacent to catalytic
residue E1833. Most likely, substitution for Y1835 altered the afﬁnity
to bind the SAM molecule or affected catalysis.
In VP39 structure, D182 and E233 also make contact with
guanosine (Hodel et al., 1996). We targeted E1764 as a candidate
for the role of D182 and E233 in VP39. Substitution of E1764 to A, D, Q
or K abolished both G-N-7 and 2'-O methylations (Fig. 6). The
predicted structure of VSV MTase also shows that E1764, the residue
adjacent to the catalytic residue D1762, is exposed to the putative
SAM binding site. The side chain of E1764 shows close contact to the
adenyl group of SAM (3.1 Å) (Fig. 8A). However, these residues are
located at different sides of the cavity of the SAM-binding and
catalytic sites. Y1650 and F1691 are on one side, whereas E1764 is on
the other, and the side chains of these three residues are all exposed
outward from the cavity. E1764 is apart from residues Y1650 and F1691
in the alpha-carbon atom distances of 16.8 and 27.0 Å, respectively.
Perhaps, E1764 may be critical for catalysis, SAM binding, or the
interactionwith theRNAchain, insteadofmediating contactwithmRNA
cap. In addition, we also found that other amino acid substitutions suchas N1692A, S1693A and S1827A affected mRNA cap methylation
(Fig. 3C). Interestingly, S197 in RRMJ has been shown to be involved
in RNA-protein interactions (Hager et al., 2004). Further functional and
structural studies of the VSVMTasewill be necessary to deﬁne the exact
role of these amino acids in mRNA cap methylation.
Model for mRNA cap recognition in a dual MTase
Our structure prediction and mutagenesis is guided by the
homology of VSV MTase with 2'-O MTases. If Y1650 and F1691 are
the cap recognition site for VSV 2'-O MTase, why does alteration in
these amino acid residues also abolish G-N-7 methylation? Perhaps,
the simplest explanation is that the order of VSV mRNA cap
methylation is unique in which 2'-O methylation is required for G-
N-7 methylation (Li et al., 2006; Rahmeh et al., 2009). Thus, inhibition
of 2'-O methylation would likely also prevent the G-N-7 methylation.
Another model is that aromatic residue Y1650 and F1691 also make
contact with the mRNA cap during G-N-7 methylation. Previously, it
was thought that no amino acid residue was in direct contact with the
guanine-N-7 nucleophile, the SAM methyl carbon, or the SAH sulfur
leaving group (Fabrega et al., 2004). Rather, cap G-N-7 methylation is
accomplished by optimally orienting the substrates in proximity to
facilitate methyl transfer (Fabrega et al., 2004). However, a recent
structural study of vaccinia G-N-7 MTase revealed that aromatic
residues (Y555 and F556) play a critical role in G-N-7 methylation
(De la Pena et al., 2007; Zheng and Shuman, 2008a,b). These aromatic
amino acids stabilize binding to the catalytic site and facilitate the
precise positioning of themethyl donor. Therefore, we cannot exclude
the possibility that Y1650 and F1691 play a role in stabilizing the
binding of VSV MTase to the cap during G-N-7 methylation.
Of course, it would be of great interest to test whether mutations
to aromatic residues inﬂuence binding of the RNA substrate in vitro. In
an attempt to demonstrate the RNA binding activity, we expressed
and puriﬁed the recombinant L mutant carrying both F1961A and
Y1650A, and their RNA binding activities were determined by a gel
shift assay. Unfortunately, these amino acid changes did not affect the
RNA binding activity in vitro (data not shown). It is likely that there
are many RNA binding sites in the 240-kDa L protein and a single
point mutation in MTase may not affect the RNA-protein complex.
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In eukaryotic cells, G-N-7 and 2'-OMTases are usually catalyzed by
separate proteins and each protein encodes its own SAM binding site
(Barbosa andMoss, 1978; Schluckebier et al., 1995; Shuman, 2001). In
the case of reovirus, two methylase activities are located in two
different domains in a single protein and each domain possesses a
SAM binding motif (Reinisch et al., 2000). To date, rhabdovirus VSV
and ﬂavivirus WNV are the two best characterized viruses that utilize
a single region in the polymerase protein for both G-N-7 and 2'-O
methylations. However, the mechanism of VSV mRNA methylation is
distinct from that of the WNV system. In VSV, 2'-O methylation
precedes and facilitates subsequent G-N-7methylation (Li et al., 2006;
Rahmeh et al., 2009). However, WNV MTases modify the cap
structure, ﬁrst at the G-N-7 position and subsequently at the ribose
2'-O position (Ray et al., 2006; Zhou et al., 2007; Dong et al., 2007). In
VSV, G-N-7 and 2'-O MTases require similar conditions for methyl-
ation with an optimal pH at 7.0 (Rahmeh et al., 2009). In contrast,
G-N-7 and 2'-O MTases of WNV require an optimal pH at 6.5 and 10,
respectively (Ray et al., 2006). Both VSV andWNVMTases modify the
RNA in a sequence-speciﬁc manner, but require different elements in
the RNA substrate. VSV G-N-7 and 2'-O MTases require speciﬁc gene
start sequences with a minimum mRNA length of 10 nucleotides
(Wang et al., 2007; Rahmeh et al., 2009). In the WNV model, N-7 cap
methylation requires speciﬁc nucleotides at the second and third
positions and a 5' stem-loop structure within the 74-nucleotide viral
RNA; in contrast, 2'-O ribose methylation requires speciﬁc nucleotides
at the ﬁrst and second positions, with a minimum 5' viral RNA of 20
nucleotides (Dong et al., 2007).
In this study, we found that there is another striking difference in
the cap recognition site between VSV and WNV MTases. In WNV
MTase, the cap recognition site is essential for 2'-O, but not G-N-7
methylation (Dong et al., 2008). Consistent with this, GTP and cap
analogs speciﬁcally inhibited 2'-O, but not G-N-7 methylation (Dong
et al., 2008). It was proposed that WNV MTase catalyzes two
methylations through a substrate-repositioning mechanism, in
which the G-N-7 methylated cap is repositioned to the cap binding
site for 2'-Omethylation upon binding (Dong et al., 2008). However, it
is unlikely that the RNA substrate binding site functions as a switching
point for VSV MTase since substitutions to this site abolished both
G-N-7 and 2'-O methylations. In agreement with this hypothesis, GTP
and cap analogs did not affect VSV mRNA cap methylation in vitro (Li
et al., unpublished observation). Previously, we and others have
performed extensive mutagenesis analysis in the MTase catalytic and
SAM binding sites (Li et al., 2005, 2006, 2007; Grdzelishvili et al.,
2005; Galloway and Wertz, 2008). Some of the mutants (G1670A and
G1672A) in the SAM binding site were defective in G-N-7, but not 2'-O
methylation (Li et al., 2006). Interestingly, none of the mutants were
speciﬁcally defective in 2'-O, but G-N-7 methylation. Most likely, the
cap recognition site in VSV MTase plays an essential role in stacking
the cap of the RNA substrate during 2'-O methylation and possibly
stabilizes the RNA-MTase complex during G-N-7methylation. Overall,
themechanism of VSVmRNA capmethylation is signiﬁcantly different
that of WNV, although both of them encode dual MTase activities in a
single domain in viral polymerase proteins. Most recently, it was
found that capping of ﬂavivirus RNA is catalyzed by conventional
RNA guanylyltransferase via a covalent GMP-enzyme intermediate
(Issur et al., 2009). However, VSV capping is catalyzed by a novel
polyribonucelotidyltransferase (PRNTase) (Ogino and Banerjee, 2007;
Li et al., 2008; Ogino et al., 2010; Koonin and Moss, 2010). These
studies suggest that VSV and perhaps other NNS RNA viruses have
evolved a unique mechanism to add the cap to their mRNA and to
methylate the cap structure.
In summary, we examined the potential RNA substrate recognition
site in VSV methlyase and determined its role in mRNA cap
methylation. We identiﬁed two aromatic amino acid residues thatare essential for both G-N-7 and 2'-O methylation and may play a
critical role in the stacking interaction with mRNA cap. Clearly,
unraveling of the crystal structure of VSV MTase will provide more
mechanistic insight to this unusual mRNA cap methylation. We also
showed that mutations to the putative RNA substrate recognition site
signiﬁcantly diminished viral replication. These ﬁndings suggest that
mRNA cap methylation is an attractive antiviral target for NNS RNA
viruses.
Materials and methods
Plasmid construction and site-directed mutagenesis
Plasmids encoding VSV N (pN), P(pP), and L (pL) genes, and an
infectious cDNA clone of the viral genome, pVSV1(+), were generous
gifts from Dr. Gail Wertz (Whelan et al., 1995). Using pVSV1(+) as a
template, the coding sequence in the L gene was modiﬁed by site-
directed mutagenesis using the QuikChange methodology (Stratagene,
La Jolla, CA). The presence of the desired mutation was conﬁrmed by
sequence analysis of a 2-kb region of pVSV1(+) that spanned from FseI
site to an HindIII site. The pVSV1(+) variants were digested with FseI
and HindIII, and the resulting 2-kb fragment was subcloned back into
pVSV1(+) at the same sites. This approach ensured that no other
sequence alterations were introduced during themutagenesis reaction.
Using this method, a total of sixteen L gene mutations was generated.
Recovery and puriﬁcation of recombinant VSV
Recovery of recombinant VSV from the infectious clone was
performed essentially as described previously (Whelan et al., 1995).
Brieﬂy, recombinant VSV was recovered by co-transfection of pVSV
(+), pN, pP, and pL into BSRT7 cells infected with a recombinant
vaccinia virus (vTF7-3) expressing T7 RNA polymerase (Fuerst et al.,
1986). At 96 h posttransfection, cell culture ﬂuids were collected,
ﬁltered through 0.2 μM ﬁlter, and recombinant virus was further
ampliﬁed in BSRT7 cells. Subsequently, the viruses were plaque
puriﬁed. Viral plaque assay was performed in Vero cells as described
previously (Whelan et al., 1995). Individual plaques were isolated,
and seed stocks were ampliﬁed on BSRT7 cells. To generate large
stocks, plaque puriﬁed viruses were inoculated into 10 conﬂuent T150
ﬂask BSRT7 cells at a multiplicity of infection (MOI) of 0.01 in a
volume of 2 ml of Dulbecco modiﬁed Eagle medium (DMEM). At 1 h
postadsorption, 15 ml of DMEM (supplemented with 2% fetal bovine
serum)was added to the cultures, and infected cells were incubated at
37 °C for 24 to 48 h. Cell culture ﬂuids were harvested when extensive
cytopathic effect (CPE) was observed. Cell culture ﬂuids were clariﬁed
by centrifugation at 3,000×g for 10 min. Virus was concentrated by
centrifugation at 40,000×g for 90 min at 4 °C in a Ty 50.2 rotor. The
pellet was resuspended in NTE buffer (100 mM NaCl, 10 mM Tris,
1 mMEDTA [pH 7.4]) and further puriﬁed through 10% sucrose NTE by
centrifugation at 150,000g for 1 h at 4 °C in an SW50.1 rotor. The ﬁnal
pellet was resuspended in 0.3 ml of NTE buffer. The virus titer was
determined by plaque assay in Vero cells, and the protein content was
measured by the Bradford assay (Sigma Chemical Co., St. Louis, MO).
The L genes of the puriﬁed viruses were sequenced again, and these
stocks were used for in vitro transcription reactions.
Single-cycle growth curves
Conﬂuent BSRT-7 cells were either infected with individual viruses
at an MOI of 3 or infected with 20 TCID50 of viruses. After 1 h of
adsorption, the inoculum was removed, the cells were washed twice
with DMEM, fresh DMEM (supplemented with 2% fetal bovine serum)
was added, and infected cells were incubated at 37 °C. Aliquots of the
cell culture ﬂuid were removed at the indicated intervals, and virus
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using Reed–Muenchmethod in BSRT7 cells (Reed andMuench, 1938).
Transcription of viral RNA in vitro
Viral RNA was synthesized in vitro essentially as described
previously (Baltimore et al., 1970; Ball and White, 1976; Li et al.,
2005, 2006, 2007). 20 μg of puriﬁed recombinant VSV was activated
by incubation with detergent for 5 min at room temperature. RNA
synthesis reactions were performed in the presence of nucleoside
triphosphates (1 mM ATP and 0.5 mM each of CTP, GTP, and UTP) and
actinomycin D. Where indicated, reactions were supplemented with
1 mM SAM or S-adenosylhomocysteine (SAH) or with 15 μCi of [α-
32P]GTP (3,000 Ci/mmol) or 15 μCi of [3H]SAM (85 Ci/mmol; Perkin-
Elmer, Wellesley, MA). After incubation at 30 °C for 5 h, total RNAwas
puriﬁed by RNeasy puriﬁcation kit (Qiagen). Puriﬁed RNA was
analyzed by electrophoresis on acid-agarose gels as described
previously (Li et al, 2005), and the products were detected by
phosphoimage analysis.
Analysis of mRNA cap methyltransferase
For G-N-7 MTase assay, in vitro transcription reactions were
performed in the presence of 15 μCi of [α-32P]GTP and 1 mM SAM or
SAH. The RNAs were puriﬁed and digested with 2U of tobacco acid
pyrophosphatase (TAP; Epicenter, Madison, WI) and the products
were resolved by thin-layer chromatography (TLC) on PEI-F cellulose
sheets (EM Biosciences). For the ribose-2'-O MTase assay, in vitro
transcription reactions were performed in the presence of 15 μCi of
[3H]SAM. The puriﬁed RNAs were digested with 5U of nuclease P1
(Sigma) or double digested by 10 U of RNase T2 and 2 U of TAP, and
the products were spotted onto a TLC plate. The TLC plate was
developed using 1.2 M LiCl2, dried in 70 °C incubator, and the
radioactive spots were detected by using a phosphorimager (GE
Healthcare, Typhoon). Markers 7mGpppA and GpppA were purchased
from New England Biolabs, and GpppAm and 7mGpppAm were
purchased from P-L Biochemicals. Marker 7mGp and Gp were
generated by TAP digestion of 7mGpppA and GpppA. All the markers
were visualized by UV shadowing at 254 nm.
Primer extension assays
A primer extension assay was used to quantify the amount of
mRNA synthesized in vitro (Li et al., 2006, 2007). Brieﬂy, a minus
sense oligonucleotide, nucleotides 130–115 of the VSV genome, was
end-labeled using [γ-32P]ATP and T4 polynucleotide kinase (Invitro-
gen). The labeled primer was puriﬁed, and 7.5 pmol was annealed
with 1/25 of the total RNA from an in vitro transcription reaction and
extended by Superscript III reverse transcriptase (Invitrogen) at 50 °C.
Products were analyzed by electrophoresis on denaturing 6%
polyacrylamide gels and detected by phosphoimage analysis.
Scintillation counting
To further analyzemRNA capmethylation, aliquots of puriﬁed RNA
from [3H] SAM experiments were mixed with 4 ml of ReadySafe
scintillation mixture (Beckman Coulter), and dpm were measured by
using a TriCarb Model 314X liquid scintillation counter (Packard
Instrument Company).
Quantitative and statistical analysis
Quantitative analysis was performed by either densitometric
scanning of autoradiographs or by using a phosphorimager (GE
Healthcare, Typhoon) and ImageQuant TL software (GE Healthcare,
Piscataway, NJ). Each experiment was done three to six times.Statistical analysis was performed by a paired Student's t test. A value
of pb0.05 was considered statistically signiﬁcant.
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